Patent Assignment
Reel/Frame 026419/0744
Assignment of Assignor's Interest
Recorded: 2011-06-09
Pages: 3
Assignor
BIONICHE TEORANTA
Executed: 2011-06-01
Assignee
BIONICHE PHARMA ACQUISITION LIMITED
UNIT 6-CASLA INDUSTRIAL ESTATE, CASLA, GALWAY, IRELAND
Covered Property
(1)
Stable Formulations of Remifentanil
Patent:
5,866,591 →
Application:
08/926,930 →
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 6, 1999
From: GLAXO WELLCOME INC.
To: ABBOTT LABORATORIES
Reel/Frame 010703/0853 →
Assignment of Assignor's Interest
Dec 16, 2008
From: ABBOTT LABORATORIES
To: BIONICHE TEORANTA
Reel/Frame 021985/0222 →
Security Agreement
Dec 16, 2008
From: BIONICHE TEORANTA
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021985/0247 →
Second Lien Ip Security Agreement
Dec 16, 2008
From: BIONICHE TEORANTA
To: ROUNDTABLE HEALTHCARE CAPITAL PARTNERS, L.P.,; ROUNDTABLE HEALTHCARE CAPITAL INVESTORS, L.P.
Reel/Frame 021985/0302 →
Assignment of Assignor's Interest
Jun 29, 2010
From: GATLIN, LARRY A.; HEIMAN, SHIRLEY A.; LEWIS, JANET S.
To: GLAXO WELLCOME INC.
Reel/Frame 024599/0852 →
Release of Security Interest in Intellectual Property
Sep 13, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: BIONICHE PHARMA GROUP LIMITED; BIONICHE TEORANTA
Reel/Frame 024973/0258 →
Release of Security Interest
Sep 13, 2010
From: ROUNDTABLE HEALTHCARE CAPITAL PARTNERS, L.P.; ROUNDTABLE HEALTHCARE CAPITAL INVESTORS, L.P.
To: BIONICHE TEORANTA
Reel/Frame 024973/0268 →
Change of Name
Jul 20, 2015
From: BIONICHE PHARMA ACQUISITION LIMITED
To: MYLAN PHARMA ACQUISITION LIMITED
Reel/Frame 036135/0170 →